Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain

• Status: Unknown status
• Trial end date: 2014-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to evaluate which treatment option for pelvic floor pain allows for improved sexual function.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Cincinnati
• Collaborator: Patty Brisben Foundation For Women's Sexual Health
• Treatments: Bupivacaine; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• pelvic pain

• pelvic floor myalgia

• dyspareunia

• female

• age > 18 years

Exclusion Criteria:

• interstitial cystitis

• vaginal lesions / ulcerations

• prior trigger point injections in the past 6 months

• prior pelvic rehabilitation in the past 6 months

• laparoscopically documented endometriosis / pelvic adhesions or adhesive disease

• documented pelvic inflammatory disease identified within the past 6 months

• documented sexually transmitted disease within the past 6 months